Development of novel anti-HCV therapies: HCV protease, helicase, and polymerase as therapeutic targets.
Department of Antiviral Therapy, Schering-Plough Research Institute, Kenilworth, New Jersey 07033, USA.
Z
Z
Hong
D N
DN
Standring
B
B
Baroudy
J Y
JY
Lau
D000998:Antiviral Agents / Q000627:therapeutic use*; D004265:DNA Helicases / Q000187:drug effects; D018076:DNA, Complementary / Q000187:drug effects; D005260:Female; D016174:Hepacivirus / Q000187:drug effects* / Q000201:enzymology* / Q000235:genetics; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D008297:Male; D011480:Protease Inhibitors / Q000627:therapeutic use; D012680:Sensitivity and Specificity; D017361:Viral Nonstructural Proteins / Q000187:drug effects
D000998:Antiviral Agents; D018076:DNA, Complementary; D011480:Protease Inhibitors; D017361:Viral Nonstructural Proteins; D004265:DNA Helicases